Linoleic acid metabolites, (-)-methyl jasmonate and (+)-12-oxophytodienoic acid ((+)-12-oxo-PDA), were prepared from the same precursor (1,2-trans, 1,3cis, 2'Z)-2-(pent-2'-enyl)-cyclopent-4-en-1,3-diol, which was obtained by regioselective pent-2-enylation of cyclopentadiene and following photooxidation to cis-1,3-diol. A methoxycarbonylmethyl substituent was introduced to the cyclopentane ring via alkylation of the -allyl palladium intermediate derived from (1R,2S,3S,2'Z)-3-acetoxy-2-(pent-2'-enyl)cyclopent-4-ene-1-ol with dimethyl malonate for (-)-methyl jasmonate. The -chain was introduced to the cyclopentane ring via the S N 2 type nucleophilic substitution of (1S,2R,3R,2'Z)-3-acetoxy-2-(pent-2'-enyl)cyclopent-4-ene-1-ol with a dialkylcuprate for (+)-12-oxo-PDA.
Biologically active natural products with a cyclopentane skeleton called "cyclopentanoids" are one of the most popular and attractive synthetic targets. Although there are many cyclopentanoid natural products that are expected to have clinical utilities and biological activity, sufficient quantities of the cyclopentanoids are not available for investigation of their properties in detail. Therefore, many chemists have made strong efforts to prepare them conveniently from cheap and easily available chemicals [1] .
For our cyclopentanoid synthesis, we adopted cyclopentadiene as a cheap source of the cyclopentane ring and introduced a side chain of the target molecules via coupling of either 3-acetoxycyclopentenes or cyclopentenones prepared from cyclopentadiene with a nucleophile as a key step of our synthesis [2] . On the other hand, we have discovered highly regioselective alkylation of cyclopentadiene and applied the method for the synthesis of both (+)-and (−)-untenone A [3] . Here we describe the synthesis of the title compounds via coupling of a nucleophilic cyclopentane ring with an electrophile to introduce a side chain as shown in the 'Retrosynthetic analysis' (Scheme 1). Scheme 1: Retrosynthetic analysis of cyclopentanoids (methyl jasmonate and 12-oxo-PDA).
Cyclopentadienyl anion, prepared from freshly distilled cyclopenta-1,3-diene (10 mmol) with sodium hydride (10 mmol) in THF at 0°C, was treated with (Z)-1-bromopent-2-ene (5 mmol) in THF at -78ºC for 3 h to obtain (2'Z)-5-(pent-2'-enyl)cyclopenta-1,3-diene Scheme 2: Preparation of (−)-6 and (+)-6.
2 regioselectively, although reactions at higher temperature for a longer time resulted in the formation of a larger amount of undesirable regioisomers (i.e., (2'Z)-1-(pent-2'-enyl)cyclopenta-1,3-diene).
Conversion of 2 to meso-diol 4 was performed via photochemical oxidation of 2 (ca. 20 mmol; crude product obtained by alkylation) to peroxide 3 by irradiation with a halogen lamp (150 W) under bubbling oxygen in the presence of rose Bengal in MeOH-THF (1:1 (v/v), 200 mL) at -40ºC for 10 h. The subsequent reduction of 3 to meso-diol 4 by treatment with thiourea afforded 4 in 72% yield based on 2 [4] . Conversion of meso-diol 4 to optically active monoacetate (−)-6 and meso-diacetate 5 to (+)-6 were both carried out enzymatically using lipase PS (Amano IM). Treatment of meso-diol 4 with lipase (25 wt%) and vinyl acetate (7 equiv.) was carried out in cyclopentyl methyl ether (CPME) at room temperature for 12 h to give mono-acetate (−)-6 in 99% yield with 99% ee. On the other hand, (+)-6 was afforded by treatment of meso-diacetate 5 with the lipase (25 wt%) in phosphate buffer-acetone (1:1, 5 mL/1 mmol of 5) at 35ºC for 19 h in 96% yield with 99% ee (Scheme 1) [5]. Total synthesis of (−)-methyl jasmonate (1) was completed from (+)-6 in 5 steps according to common methods. Then, we tried to convert (+)-8 to (−)-1 in a single step by isomerization of allylic alcohol to ketone using either Marko's [6a] or Ikariya's method [6b], because the conventional method to convert (+)-8 to (−)-1 required 3 steps (Scheme 2).
Treatment of (+)-8 with 10 mol% of tetrapropylammonium perruthenate (TPAP) in fluorobenzene in the presence of 2-undecanol and cyclohexene [6a] was carried out to give (-)-1 directly. The results are summarized in Table 1 . The method was very promising for the conversion of (+)-8 to (-)-1; a satisfactory yield (71%) was obtained with 21% recovery of (+)-8 (entry 1 in Table 1 ). However, we could not find a reaction condition to give (-)-1 without isomerization of the olefin moiety of the side chain Z to E. Alternatively, we tried the conversion of (+)-8 to 1 using 10 mol% of Cp*RuCl(cod) (Cp* =  5 -C 5 (CH 3 ) 5 , cod = 1,5-cyclooctadiene) in the presence of potassium tert-butoxide (10 mol%) and 2-diphenylphosphinoethylamine (10 mol%) in toluene at 40ºC for 12 h, which give (−)-1 in 55% yield together with 10 (7%) and (+)-8 (13% recovery) [6b]. It became clear that no racemization, no epimerization, and no isomerization of the Z-olefin of (−)-1 occurred under the reaction conditions, although longer reaction times (i.e., for 90 h) never gave a better yield than that for 12 h.
Next, we employed (−)-6 for the synthesis of (+)-12-oxo-PDA ((+)-11) [7] according to the method reported by Kobayashi and coworkers, as shown in Figure 1 and Scheme 4 [7b]. Over three equivalents of Grignard reagent, 8-tert-butyldiphenylsilyloxyoctylmagnesium chloride, was prepared in either THF (entries 1-8) or THP (tetrahydropyran, entry 9) in high concentration (>1 M) at 100ºC and was treated with CuCN (10 mol%) in THF for 30 min. To the THF solution of a mixture of Grignard reagent and CuCN, THF solution of (−)-6 was added dropwise, except for entries 6 and 7. The typical results are summarized in Table 2 . a Grignard reagent was prepared from 8-t-butyldiphenylsilyloxyoctyl chloride (1.5 mmol: entries 1-7; 3.0 mmol: entries 8 and 9) and 1.1 equiv. of magnesium turnings in THF or THP (> 1.0 M) at 110ºC. To the THF suspension of CuCN was added diluted Grignard reagent (ca. 4 M) and the reaction mixture was stirred for 30 min, and then (−)-6 in THF (1 mL) was added dropwise and stirred. b Solvent in which Grignard reagent was prepared. THP = tetrahydropyran. c The reaction was performed in Et 2 O using THF solution of Grignard reagent. d To the THF solution of (−)-6 was added a cuprate, prepared from Grignard reagent and CuCN in THF, at -18ºC and stirred for 3 h. e Grignard reagent was prepared from 3.0 mmol of the chloride and 3.3 mmol of magnesium turnings in THF. f Grignard reagent was prepared from 3.0 mmol of the chloride and 3.3 mmol of magnesium turnings in THP.
We optimized the reaction conditions to give (+)-12 in good yield; 33% yield [(+)-12/13 >1/2] in the presence of 15 mol% of CuCN and excess Grignard reagent at -18ºC (entry 8 in Table 2 ). We finally obtained (+)-12 in >40% isolated yield [(+)-12/13 > 4/5] using Grignard reagent prepared in THP. This result is very surprising, because (+)-12 is sterically more hindered than its regioisomeric byproduct 13, although the reason is not clear at present. Removal of the silyl group of (+)-12 with TBAF, followed by Jones oxidation of the resulting (+)-14 accomplished the total synthesis of (+)-12-oxo-PDA (+)-11 [7b].
Scheme 4: Synthesis of (+)-12-oxo-PDA.
Experimental
General: All reactions were carried out under an argon atmosphere. Anhydrous solvents were purchased from Wako Pure Chemical Co., Inc. Reagents were purchased of the highest commercial quality and used without further purification. The IR spectra were measured on a JASCO FT/IR 500 spectrophotometer. Mass spectra, including high-resolution spectra, were recorded on a JEOL JMS-700 MStation. 1 H and 13 C NMR spectra were measured on a JEOL 400 (400 MHz and 100 MHz, respectively) spectrometer. Silica gel BW-300 (200-400 mesh; Fuji Silysia) was used for column chromatography, and silica-gel 60F 254 plates (0.25 mm; Merck) were used for TLC.
(2'Z)-5-(Pent-2'-enyl)cyclopenta-1,3-diene (Compound 2): Sodium hydride (0.8 g, 20 mmol; 60% dispersion in mineral oil) Preparation of (-)-methyl jasmonate and (+)-12-oxophytodienoic acid Natural Product Communications Vol. 8 (7) 2013 921 was washed with dry n-hexane twice in a two necked reaction vessel and the remaining n-hexane was removed under reduced pressure. To the THF (17 mL) suspension of the washed NaH was added cyclopentadiene (1.55 mL, 20 mmol) at 0ºC and the reaction mixture was stirred for 30 min. To the THF solution of cyclopentadienyl sodium was slowly added Z-1-bromopent-2-ene (1.57 g, 20 mmol) in 2 mL of THF solution at -78ºC and stirred for 2 h. The reaction mixture was poured into 100 mL of cold diethylether (cooled under 0ºC) and washed with 50 mL of cold brine (cooled under 0ºC). The organic layer was separated and dried on magnesium sulfate under 0ºC, and concentrated under 0ºC to give the crude product quantitatively. The 1 H NMR spectrum of the crude product measured after 30 min at room temperature showed that the purity of 2 was over 90% (including a small amount of regioisomer; <10%). The crude product was used for the next step. 1 
(1S,2R,3R,2'Z)-3-Acetoxy-2-(pent-2'-enyl)cyclopent-4-ene-1-ol (Compound (−)-6):
To a solution of 4 (336 mg, 2 mmol) in CPME (20 mL) was added vinyl acetate (1.3 mL) and 84 mg of Lipase SP (Amano IM), and the reaction mixture was stirred at 20ºC for 12 h. The reaction mixture was filtered through Celite and the filtrate was concentrated in vacuo. The residue was filtrated through silica gel to give (1S,2R,3R,2'Z)-3-acetoxy-2-(pent-2'-enyl)cyclopent-4-ene-1-ol, (-)-6 (416 mg, 99% yield) with >99% ee. Rf: 0.53 (ethyl acetate: n-hexane, 1/1). 
(3,4-trans, 3,5-cis, 2'Z)-3,5-Diacetoxy-4-(pent-2'-enyl)cyclopentene (Compound 5):
To a pyridine (2 mL) solution of diol 4 (1.24 g, 6.3 mmol) was added DMAP (40 mg) and acetic anhydride (2 mL) and the reaction mixture was stirred for 1 h at room temperature. After usual workup, the crude product was purified by passing trough a short silica gel column to give diacetate 5 (1.48 g, 93% yield). Rf: 0.83 (ethyl acetate: n-hexane, 1/1). IR (neat): 2963, 1744, 1439, 1364, 1231, 1020, 978, 793 cm-1. 1 
(1R,2S,3S,2'Z)-3-Acetoxy-2-(pent-2'-enyl)cyclopent-4-ene-1-ol (Compound (+)-6):
To a solution of diacetate 5 (1.0 g) in acetone (10 mL) was added phosphate buffer (pH 7, 10 mL) and Lipase PS (Amano IM, 4 g) and the reaction mixture was stirred at 35ºC with monitoring for the diminishing of 5 by TLC. After ca. 20 h, the reaction mixture was filtered through Celite with washing by ethyl acetate and the organic filtrate was dried on magnesium sulfate and concentrated in vacuo, and the residue purified by CC on silica gel to give (+)-6 in 96% yield (0.8 g) with >99% ee. Rf 
(1R,2R,3S,2'Z)-3-Bis(methoxycarbonyl)methyl-2-(pent-2'-enyl)cyclopent-4-en-1-ol (Compound (+)-7):
To a suspension of t-BuOK (410 mg, 3.65 mmol) in THF (10 mL) was added dimethylmalonate (0.44 mL, 3.65 mmol) at 0ºC and stirred for 30 min. To the solution was added Pd(PPh 3 ) 4 (96 mg, 0.083 mmol) and (+)-6 (349 mg, 1.66 mmol) under a nitrogen atmosphere and the reaction mixture was stirred at 35ºC for 4 h. The reaction was quenched by saturated aqueous ammonium chloride and the reaction mixture was extracted with ethyl acetate. The extract was dried and concentrated in vacuo. The residue was purified by CC on silica gel to give (+)-7 in 94% yield (451 mg). When the reaction was performed with Pd(OAc) 2 (5 mol%) and PPh 3 (10 mol%) as a catalyst, (+)-7 was obtained in 91% yield. Rf: 0.33 (ethyl acetate: n-hexane, 1/2). 
(2R,3R,2'Z)-3-(Methoxycarbonyl)methyl-2-(pent-2'-enyl)-cyclopentanol (Compound 10):
To the methanol solution of (+)-9 (89 mg, 0.4 mmol) was added sodium borohydride (25 mg, 0.6 mmol) and the reaction mixture was stirred at room temperature for 20 min, and then concentrated in vacuo. The residue was diluted with ethyl acetate and washed with brine. The organic layer was separated, dried on magnesium sulfate and concentrated in vacuo. The crude product (ca. 90 mg) was used for the next step without purification. Rf: 0.47 and 0.58 (ethyl acetate: n-hexane, 1/2). . 13 C NMR (CDCl 3 ):14.4 (CH 3 ), 19.3 (C), 20.7 (CH 2 ), 25.8 (CH 2 ), 26.9 (3 x CH 3 ), 27.9 (CH 2 ), 29.4 (CH 2 ), 29.6 (CH 2 ), 29.9 (CH 2 ), 31.6 (CH 2 ), 32.6 (CH 2 ), 34.3 (CH 2 ), 54.2 (CH), 54.5 (CH), 64.0 (CH 2 ), 84.0 (CH), 126.7 (CH), 127.5 (4 x CH), 129.4 (2 x CH), 131.7 (CH), 132.5 (CH), 133.1 (2 x C), 134.0 (CH), 135.5 (4 x CH).
